UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported)
___________________________________________________________
ACURA PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in Charter)
___________________________________________________________
State of New York | 1-10113 | 11-0853640 |
(State of Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
| | | |
| | 616 N. North Court, Suite 120 Palatine, Illinois 60067 (Address of principal executive offices) (Zip Code) (847) 705-7709 (Registrant’s telephone number, including area code) | |
| | | |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o› Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o› Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o› Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
o› Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e- 4(c))
Item 8.01 Other Events
On December 11, 2006, the Registrant issued the Press Release attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
| Exhibit Number | Description |
| 99.1 | Press Release dated December 11, 2006 Announcing Notice of Allowance For Issuance of Patent for Deterring Abuse of Opioid Containing Dosage Forms |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | |
| | ACURA PHARMACEUTICALS, INC. |
|
|
|
| | By: | /s/ Peter Clemens |
| |
Peter A. Clemens |
| | Senior Vice President & Chief Financial Officer |
| Date: December 11, 2006 | |
Exhibit Index
| Exhibit Number | Description |
| 99.1 | Press Release dated December 11, 2006 Announcing Notice of Allowance For Issuance of Patent for Deterring Abuse of Opioid Containing Dosage Forms |
